• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对称 1,8-二取代酰胺基蒽醌类化合物的设计、合成及对端粒酶抑制、hTERT 抑制和抗增殖活性的评价。

Design, synthesis and evaluation of telomerase inhibitory, hTERT repressing, and anti-proliferation activities of symmetrical 1,8-disubstituted amidoanthraquinones.

机构信息

Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan.

出版信息

Eur J Med Chem. 2012 Apr;50:102-12. doi: 10.1016/j.ejmech.2012.01.044. Epub 2012 Feb 1.

DOI:10.1016/j.ejmech.2012.01.044
PMID:22357112
Abstract

A series of symmetrical disubstituded 1,8-diamidoanthraquinones were synthesized and evaluated for anti-proliferation, telomerase inhibitory by TRAP assay, and hTERT expression by SEAP assay. All of the compounds tested, except for compounds 3a and 3s were selected by the NCI screening system. In addition, compounds 4e and 4k exhibited inhibitory effects on telomerase activity. Taken together, our findings indicated that the analysis of cytotoxicity and telomerase inhibition might provide information applicable for further developing potential telomerase targeting strategy.

摘要

一系列对称取代的 1,8-二酰胺基蒽醌被合成,并通过 TRAP assay 评估其抗增殖、端粒酶抑制以及 SEAP assay 评估 hTERT 表达的活性。除化合物 3a 和 3s 外,所有测试的化合物均通过 NCI 筛选系统进行了选择。此外,化合物 4e 和 4k 表现出对端粒酶活性的抑制作用。综上所述,我们的研究结果表明,细胞毒性和端粒酶抑制分析可能提供适用于进一步开发潜在的端粒酶靶向策略的信息。

相似文献

1
Design, synthesis and evaluation of telomerase inhibitory, hTERT repressing, and anti-proliferation activities of symmetrical 1,8-disubstituted amidoanthraquinones.对称 1,8-二取代酰胺基蒽醌类化合物的设计、合成及对端粒酶抑制、hTERT 抑制和抗增殖活性的评价。
Eur J Med Chem. 2012 Apr;50:102-12. doi: 10.1016/j.ejmech.2012.01.044. Epub 2012 Feb 1.
2
Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives.新型不对称 1,2-二取代酰胺蒽醌衍生物的合成、抗增殖活性及端粒酶抑制作用评价。
Eur J Med Chem. 2012 Jan;47(1):323-36. doi: 10.1016/j.ejmech.2011.10.059. Epub 2011 Nov 7.
3
Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.基于结构的新型蒽并[1,2-d]咪唑-6,11-二酮衍生物的设计、合成与评价作为端粒酶抑制剂及用于癌症多药理学的潜力。
Eur J Med Chem. 2013 Feb;60:29-41. doi: 10.1016/j.ejmech.2012.11.032. Epub 2012 Nov 29.
4
Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones.区域异构体二取代氨基蒽醌和氨基蒽醌对人端粒酶的抑制作用及细胞毒性。
Bioorg Med Chem. 2005 Mar 1;13(5):1435-44. doi: 10.1016/j.bmc.2004.12.036.
5
Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone.一些新的蒽醌对称双取代衍生物对人端粒酶逆转录酶表达的激活作用。
J Med Chem. 2003 Jul 17;46(15):3300-7. doi: 10.1021/jm020492l.
6
Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.一系列2,7-双取代氨基蒽醌衍生物的合成、人端粒酶抑制及抗增殖研究
Bioorg Med Chem. 2008 Jul 15;16(14):6976-86. doi: 10.1016/j.bmc.2008.05.072. Epub 2008 Jun 2.
7
Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones.一系列区域异构体二取代氨基蒽醌的合成及其对人端粒酶的抑制作用
Chem Pharm Bull (Tokyo). 2007 Feb;55(2):284-92. doi: 10.1248/cpb.55.284.
8
Synthesis, telomerase evaluation and anti-proliferative studies on various series of diaminoanthraquinone-linked aminoacyl residue derivatives.各种系列二氨基蒽醌连接的氨酰残基衍生物的合成、端粒酶评价和抗增殖研究。
Arch Pharm (Weinheim). 2012 Feb;345(2):101-11. doi: 10.1002/ardp.201100122. Epub 2011 Sep 29.
9
Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents.基于结构的新型蒽[1,2-d]咪唑-6,11-二酮类似物的设计、合成与生物评价及其作为潜在抗肿瘤剂的研究。
Eur J Med Chem. 2013 Nov;69:278-93. doi: 10.1016/j.ejmech.2013.06.058. Epub 2013 Aug 9.
10
1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase.作为人类端粒酶抑制剂的1,4-和2,6-二取代氨基蒽醌-9,10-二酮衍生物
J Med Chem. 1998 Aug 13;41(17):3253-60. doi: 10.1021/jm9801105.

引用本文的文献

1
Therapeutic potential of EGFR/mTOR/Nf-kb targeting small molecule for the treatment of non-small cell lung cancer.表皮生长因子受体/雷帕霉素靶蛋白/核因子-κB靶向小分子在非小细胞肺癌治疗中的治疗潜力
Am J Cancer Res. 2023 Jun 15;13(6):2598-2616. eCollection 2023.
2
study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates.新型氯硝柳胺衍生物的研究,即针对严重急性呼吸综合征冠状病毒2非结构蛋白催化残基的小分子候选药物。
Arab J Chem. 2023 May;16(5):104654. doi: 10.1016/j.arabjc.2023.104654. Epub 2023 Feb 8.
3
Deciphering the immuno-pathological role of FLT, and evaluation of a novel dual inhibitor of topoisomerases and mutant-FLT3 for treating leukemia.
解析FLT的免疫病理作用,以及评估一种新型拓扑异构酶和突变型FLT3双重抑制剂治疗白血病的效果。
Am J Cancer Res. 2022 Nov 15;12(11):5140-5159. eCollection 2022.
4
A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling.GBM-N019 作为一种通过外泌体 mTOR/CDK6/STAT3 信号抑制胶质母细胞瘤的潜在抑制剂的临床前研究。
Cells. 2021 Sep 11;10(9):2391. doi: 10.3390/cells10092391.
5
Application of Amino Acids in the Structural Modification of Natural Products: A Review.氨基酸在天然产物结构修饰中的应用:综述
Front Chem. 2021 Apr 29;9:650569. doi: 10.3389/fchem.2021.650569. eCollection 2021.
6
Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation.一类新型WNT1抑制剂的鉴定:癌细胞迁移、G-四链体稳定及靶点验证
Oncotarget. 2016 Oct 18;7(42):67986-68001. doi: 10.18632/oncotarget.6622.
7
Causes of genome instability: the effect of low dose chemical exposures in modern society.基因组不稳定的原因:现代社会中低剂量化学暴露的影响。
Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S61-88. doi: 10.1093/carcin/bgv031.
8
Urine telomerase for diagnosis and surveillance of bladder cancer.尿液端粒酶用于膀胱癌的诊断和监测。
Adv Urol. 2012;2012:693631. doi: 10.1155/2012/693631. Epub 2012 Jul 25.